{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:11:01Z","timestamp":1780567861033,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.neuropharm.2023.109466","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T20:21:07Z","timestamp":1676492467000},"page":"109466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Beneficial effects of arketamine on the reduced bone mineral density in susceptible mice after chronic social defeat stress: Role of the gut\u2013microbiota\u2013bone\u2013brain axis"],"prefix":"10.1016","volume":"228","author":[{"given":"Xiayun","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109466_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115552","article-title":"Current anti-depressant use is associated with cortical bone deficits and reduced physical function in elderly women","volume":"140","author":"Agarwal","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.neuropharm.2023.109466_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainresbull.2022.02.004","article-title":"Brain-gut-microbiota axis in depression: a historical overview and future directions","volume":"182","author":"Chang","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2023.109466_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tem.2009.05.003","article-title":"Depression as a risk factor for osteoporosis","volume":"20","author":"Cizza","year":"2009","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-0030-1252020","article-title":"Depression and osteoporosis: a research synthesis with meta-analysis","volume":"42","author":"Cizza","year":"2010","journal-title":"Horm. Metab. Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109466_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","article-title":"PICRUSt2 for prediction of metagenome functions","volume":"38","author":"Douglas","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/npr2.12132","article-title":"Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine","volume":"40","author":"Fujita","year":"2020","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2023.109466_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bone.2014.05.016","article-title":"New developments in biological markers of bone metabolism in osteoporosis","volume":"66","author":"Garnero","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.neuropharm.2023.109466_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116565","article-title":"Association of mental disorders and psychotropic medications with bone texture as measured with trabecular bone score","volume":"165","author":"Hafizi","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.neuropharm.2023.109466_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109466_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109466_bib12","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1038\/s41380-022-01587-7","article-title":"Ketamine: anesthetic, psychotomimetic, antidepressant, or anthelmintic?","volume":"27","author":"Hashimoto","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109466_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-023-01570-5","article-title":"Arketamine for cognitive impairment in psychiatric disorders","author":"Hashimoto","year":"2023","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109466_bib14","article-title":"Neuroinflammation through the vagus nerve\u2013dependent gut\u2013microbiota\u2013brain axis in treatment-resistant depression","author":"Hashimoto","year":"2023","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109466_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semcdb.2021.06.022","article-title":"The microbiome: a heritable contributor to bone morphology?","volume":"123","author":"Hernandez","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib16","doi-asserted-by":"crossref","first-page":"16m11276","DOI":"10.4088\/JCP.16m11276","article-title":"Association between bone mineral density and depressive symptoms in a Population-based sample","volume":"79","author":"Hlis","year":"2018","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109466_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109272","article-title":"Depression and antidepressant effects of ketamine and its metabolites: the pivotal role of gut microbiota","volume":"220","author":"Hua","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109466_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ypmed.2018.05.008","article-title":"Nutrition status, bone mass density, and selective serotonin reuptake inhibitors","volume":"113","author":"Kindilien","year":"2018","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109466_bib19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109466_bib53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00406-020-01110-5","article-title":"Intravenous arketamine for treatment-resistant depression: open-labeled pilot study","volume":"271","author":"Leal","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109466_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actions in inflammatory bowel disease","volume":"17","author":"Levelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib21","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100451R","article-title":"Gut microbiota and bone metabolism","volume":"35","author":"Lu","year":"2021","journal-title":"Faseb. J."},{"issue":"21","key":"10.1016\/j.neuropharm.2023.109466_bib22","first-page":"3123","article-title":"STAMP: statistical analysis of taxonomic and functional profiles","volume":"30","author":"Parks","year":"2014","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109466_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.tplants.2016.01.006","article-title":"Mannitol in plants, fungi, and plant-fungal interactions","volume":"21","author":"Patel","year":"2016","journal-title":"Trends Plant Sci."},{"key":"10.1016\/j.neuropharm.2023.109466_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.115020","article-title":"Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: a role of gut\u2013microbiota\u2013brain axis","author":"Qu","year":"2023","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2023.109466_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16060-7","article-title":"Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model","volume":"7","author":"Qu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109466_bib26","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","article-title":"Antidepressant medications and osteoporosis","volume":"51","author":"Rizzoli","year":"2012","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109466_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.489","article-title":"Bone density and depressive disorder: a meta-analysis","volume":"6","author":"Schweiger","year":"2016","journal-title":"Brain Behav"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109466_bib29","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/es5002105","article-title":"Identifying small molecules via high resolution mass spectrometry: communicating confidence","volume":"48","author":"Schymanski","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib30","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.3390\/ijms22179452","article-title":"The human gut microbiota: a key mediator of osteoporosis and osteogenesis","volume":"22","author":"Seely","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109466_bib31","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109466_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/PSY.0000000000000292","article-title":"Depression and reduced bone mineral density at the hip and lumbar spine: a comparative meta-analysis of studies in adults 60 years and older","volume":"78","author":"Stubbs","year":"2016","journal-title":"Psychosom. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109466_bib33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2023.109466_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/JLB.3MR0321-755R","article-title":"The microbiota-gut-bone axis and bone health","volume":"110","author":"Tu","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.afos.2017.05.002","article-title":"Serotonin reuptake inhibitors and bone health: a review of clinical studies and plausible mechanisms","volume":"3","author":"Wadhwa","year":"2017","journal-title":"Osteoporos. Sarcopenia"},{"key":"10.1016\/j.neuropharm.2023.109466_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109139","article-title":"Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: a role of gut microbiota","volume":"213","author":"Wan","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109466_bib37","article-title":"Impact of broad-spectrum antibiotics on the gut\u2013microbiota\u2013spleen\u2013brain axis","volume":"27","author":"Wan","year":"2023","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.neuropharm.2023.109466_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105951","article-title":"Key role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain","volume":"176","author":"Wang","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2023.109466_bib39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109466_bib40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2022.02.008","article-title":"Brain-spleen axis in health and diseases: a review and future perspective","volume":"182","author":"Wei","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2023.109466_bib41","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00198-009-0918-x","article-title":"Depression and low bone mineral density: a meta-analysis of epidemiologic studies","volume":"20","author":"Wu","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.neuropharm.2023.109466_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111904","article-title":"Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model","volume":"368","author":"Xiong","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109466_bib43","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41398-017-0031-4","article-title":"Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109466_bib44","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109466_bib54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109466_bib45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.biopsych.2009.03.016","article-title":"Major depression is a risk factor for low bone mineral density: a meta-analysis","volume":"66","author":"Yirmiya","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109466_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112397","article-title":"Beneficial effects of anti-RANKL antibody in depression-like phenotype, inflammatory bone markers, and bone mineral density in male susceptible mice after chronic social defeat stress","volume":"379","author":"Zhang","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109466_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S(+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2023.109466_bib48","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"2022 218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109466_bib49","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ijnp\/pyx100","article-title":"Role of inflammatory bone markers in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model","volume":"21","author":"Zhang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109305","article-title":"Ketamine and its metabolites: potential as novel treatments for depression","volume":"222","author":"Zhang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109466_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211047130","article-title":"The role of gut mycobiome in health and diseases","volume":"14","author":"Zhang","year":"2021","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.neuropharm.2023.109466_bib52","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4014\/jmb.2104.04016","article-title":"Bone homeostasis and gut microbial-dependent signaling pathways","volume":"31","author":"Zhong","year":"2021","journal-title":"J. Microbiol. Biotechnol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:22:26Z","timestamp":1758439346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":54,"alternative-id":["S0028390823000564"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109466","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of arketamine on the reduced bone mineral density in susceptible mice after chronic social defeat stress: Role of the gut\u2013microbiota\u2013bone\u2013brain axis","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109466"}}